Europeans to fight tuberculosis with innovative technique

A European team of scientists is working on making new tuberculosis treatments a reality by developing better diagnostic imaging technology. The study is supported by the PREDICT-TB ('Model-based preclinical development of anti-tuberculosis drug combinations') project, which has clinched almost EUR 14.8 million from the Innovative Medicines Initiative (IMI) under the EU's Seventh Framework Programme (FP7). IMI is a public-private partnership between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA).